RECCE PHARMACEUTICALS LTD

RECCE PHARMACEUTICALS LTD is an Australian pharmaceutical company developing a new class of synthetic anti-infectives designed to address antibiotic-resistant superbugs. Headquartered in Sydney, Australia. Here are key aspects of the company:

• Products & Services: Proprietary new class of anti-infectives effective against bacteria and viruses, including those with hyper-cellular mutations; multiple clinical indications and formulations currently in Phase I, II, and a registrational Phase III trial in Indonesia.
• Innovation & Technology: A universal mechanism of action capable of overcoming bacterial and viral mutation, ensuring drug potency does not diminish even with repeated use. RECCE PHARMACEUTICALS LTD is known for developing synthetic anti-infectives that maintain their effectiveness against mutated antibiotic-resistant pathogens through a unique universal mechanism of action.